Literature DB >> 11920765

Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.

Giuseppe De Rosa1, Fabiana Quaglia, Maria Immacolata La Rotonda, Martine Appel, Huguette Alphandary, Elias Fattal.   

Abstract

In this article, microspheres able to induce the controlled release of oligonucleotide/polyethylenimine complexes are proposed. A model oligonucleotide (the oligothymidilate pdT16) was encapsulated within poly(lactide-co-glycolide) microspheres alone or associated with polyethylenimine (PEI) at different nitrogen/phospate (N/P) ratios. Microspheres were prepared by the multiple emulsion-solvent evaporation technique and characterized for morphology, diameter, encapsulation efficiency, and release kinetics. The introduction of PEI in the internal aqueous phase resulted in the formation of a soluble complex with pdT16 and in a strong increase of the oligonucleotide encapsulation efficiency. PEI affected microsphere morphology inducing the formation of very porous particles yielding to an accelerated release of pdT16. When incubated with HeLa cells, microspheres encapsulating pdT16/PEI complexes allowed both a reduction of the complex toxicity and an improvement of the intracellular penetration of the released oligonucleotide. We conclude that biodegradable microspheres encapsulating oligonucleotides/PEI complexes have a great potential as controlled release system because they allow the sustained release of an oligonucleotide carrier that crosses biological membranes and locates in nucleus. Copyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920765     DOI: 10.1002/jps.10063

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

Review 1.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

2.  Modulation of polyplex release from biodegradable microparticles through poly(ethylenimine) modification and varying loading concentration.

Authors:  Clark J Needham; Sarita R Shah; Paschalia M Mountziaris; F Kurtis Kasper; Antonios G Mikos
Journal:  Pharm Res       Date:  2013-07-25       Impact factor: 4.200

3.  Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation.

Authors:  Amit Rawat; Quamrul H Majumder; Fakhrul Ahsan
Journal:  J Control Release       Date:  2008-03-21       Impact factor: 9.776

4.  Inhibition of the EGFR with nanoparticles encapsulating antisense oligonucleotides of the EGFR enhances radiosensitivity in SCCVII cells.

Authors:  Yehui Ping; Zou Jian; Zhang Yi; Zhao Huoyu; Liu Feng; Yang Yuqiong; Liu Shixi
Journal:  Med Oncol       Date:  2009-08-04       Impact factor: 3.064

5.  Polymeric nanoparticles for siRNA delivery and gene silencing.

Authors:  Yogesh Patil; Jayanth Panyam
Journal:  Int J Pharm       Date:  2008-10-01       Impact factor: 5.875

6.  Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.

Authors:  Janjira Intra; Aliasger K Salem
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

7.  Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.

Authors:  Janjira Intra; Aliasger K Salem
Journal:  J Drug Target       Date:  2010-08-03       Impact factor: 5.016

Review 8.  Nanoparticle-based targeted therapeutics in head-and-neck cancer.

Authors:  Ting-Ting Wu; Shui-Hong Zhou
Journal:  Int J Med Sci       Date:  2015-01-12       Impact factor: 3.738

9.  Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides.

Authors:  Shashank R Sirsi; Rebecca C Schray; Margaret A Wheatley; Gordon J Lutz
Journal:  J Nanobiotechnology       Date:  2009-04-07       Impact factor: 10.435

Review 10.  Nano and microtechnologies for the delivery of oligonucleotides with gene silencing properties.

Authors:  Giuseppe De Rosa; Maria Immacolata La Rotonda
Journal:  Molecules       Date:  2009-07-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.